Dr. Reddy’s Laboratories Limited reported Total Income for Q4 FY23 of ₹6,453.7 Crore up from ₹5,596.8 Crore year on year, a growth of 15.3%. Consolidated Net Profit of ₹960.1 Crore, surged from ₹97 Crore in the same quarter of the previous year. The Earnings per Share is ₹57.68, from ₹5.83 in the same quarter of the previous year.
Dr Reddy’s Laboratories Q4 FY23; Net Profit Surged Up To ₹960 Crore
Tags: pharmaceuticals
Related Post
- Kellton Tech Solutions Limited posts double-digit Q3 FY26 growth as digital transformation drives revenue; margins improve
Kellton Tech Solutions Limited (NSE: KELLTONTEC, BSE: 519602) reported double-digit year-on-year growth in revenue and…
-
Inox Green Energy Services Limited approves Q3 FY26 results and reappoints whole-time director
Inox Green Energy Services Limited (NSE: INOXGREEN, BSE: 543667) said its board approved the unaudited…
-
Huhtamaki India Limited reports flat Q4 2025 sales as margins improve on favorable mix and efficiency gains
Huhtamaki India Limited (NSE: HUHTAMAKI, BSE: 509820) reported broadly flat revenue in the fourth quarter…